NLRP3 and post-traumatic stress disorder: Both genetic deletion and pharmacologic blockade of the NLRP3 inflammasome may improve extinction of contextual fear memory and reduce anxiety-like behavior, offering a novel therapy for trauma and stress-related disorders such as PTSD (Dong et al. 2020).